Quest Diagnostics current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Quest Diagnostics's current ratio is 1.70: current assets of 3.12B USD against current liabilities of 1.83B USD due within a year.
- Today
- 1.70
- Average, 5 years
- 1.27
- Low, 5 years
- 0.92
- High, 5 years
- 1.70
Current ratio = current assets ÷ current liabilities = 3.12B ÷ 1.83B = 1.70
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 1.70 | 3.12B | 1.83B | |
| FY2025 | 31 Dec 2025 | 1.04 | 2.38B | 2.28B |
| FY2024 | 31 Dec 2024 | 1.10 | 2.39B | 2.17B |
| FY2023 | 31 Dec 2023 | 1.31 | 2.37B | 1.82B |
| FY2022 | 31 Dec 2022 | 1.22 | 1.90B | 1.55B |
| FY2021 | 31 Dec 2021 | 1.56 | 2.74B | 1.75B |
| FY2020 | 31 Dec 2020 | 1.72 | 3.06B | 1.78B |
| FY2019 | 31 Dec 2019 | 1.25 | 2.49B | 1.99B |
| FY2018 | 31 Dec 2018 | 0.94 | 1.39B | 1.49B |
| FY2017 | 31 Dec 2017 | 1.24 | 1.31B | 1.06B |
| FY2016 | 31 Dec 2016 | 1.56 | 1.53B | 981.00M |
| FY2015 | 31 Dec 2015 | 1.28 | 1.50B | 1.17B |
| FY2014 | 31 Dec 2014 | 0.94 | 1.60B | 1.71B |
| FY2013 | 31 Dec 2013 | 1.22 | 1.38B | 1.13B |
| FY2012 | 31 Dec 2012 | 1.49 | 1.56B | 1.05B |
| FY2011 | 31 Dec 2011 | 0.90 | 1.40B | 1.56B |
| FY2010 | 31 Dec 2010 | 1.32 | 1.61B | 1.21B |
| FY2009 | 31 Dec 2009 | 1.59 | 1.68B | 1.06B |
| FY2008 | 31 Dec 2008 | 1.22 | 1.50B | 1.22B |
| FY2007 | 31 Dec 2007 | 1.07 | 1.37B | 1.29B |
| FY2006 | 31 Dec 2006 | 1.03 | 1.19B | 1.15B |
| FY2005 | 31 Dec 2005 | 0.97 | 1.07B | 1.10B |
| FY2004 | 31 Dec 2004 | 0.89 | 931.08M | 1.04B |
| FY2003 | 31 Dec 2003 | 1.38 | 995.79M | 723.80M |
| FY2002 | 31 Dec 2002 | 1.30 | 824.44M | 635.98M |
| FY2001 | 31 Dec 2001 | 1.33 | 876.51M | 658.62M |
| FY2000 | 31 Dec 2000 | 1.03 | 980.69M | 954.99M |
| FY1999 | 31 Dec 1999 | 1.24 | 872.70M | 701.20M |
| FY1998 | 31 Dec 1998 | 1.87 | 578.20M | 309.50M |
| FY1997 | 31 Dec 1997 | 1.94 | 571.90M | 295.10M |
| FY1996 | 31 Dec 1996 | 2.05 | 510.97M | 249.43M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.70 | 3.12B | 1.83B |
| Q2 FY2026 | 30 Jun 2026 | 1.59 | 2.84B | 1.79B |
| Q1 FY2026 | 31 Mar 2026 | 1.18 | 2.57B | 2.18B |
| Q4 FY2025 | 31 Dec 2025 | 1.04 | 2.38B | 2.28B |
| Q3 FY2025 | 30 Sept 2025 | 1.13 | 2.41B | 2.13B |
| Q2 FY2025 | 30 Jun 2025 | 1.09 | 2.20B | 2.02B |
| Q1 FY2025 | 31 Mar 2025 | 1.44 | 2.08B | 1.44B |
| Q4 FY2024 | 31 Dec 2024 | 1.10 | 2.39B | 2.17B |
| Q3 FY2024 | 30 Sept 2024 | 1.25 | 2.62B | 2.09B |
| Q2 FY2024 | 30 Jun 2024 | 1.00 | 2.02B | 2.01B |
| Q1 FY2024 | 31 Mar 2024 | 0.97 | 2.23B | 2.30B |
| Q4 FY2023 | 31 Dec 2023 | 1.31 | 2.37B | 1.82B |
| Q3 FY2023 | 30 Sept 2023 | 1.12 | 1.82B | 1.62B |
| Q2 FY2023 | 30 Jun 2023 | 0.92 | 1.73B | 1.88B |
| Q1 FY2023 | 31 Mar 2023 | 1.34 | 1.81B | 1.36B |
| Q4 FY2022 | 31 Dec 2022 | 1.22 | 1.90B | 1.55B |
| Q3 FY2022 | 30 Sept 2022 | 1.46 | 2.33B | 1.60B |
| Q2 FY2022 | 30 Jun 2022 | 1.54 | 2.43B | 1.58B |
| Q1 FY2022 | 31 Mar 2022 | 1.46 | 2.48B | 1.70B |
| Q4 FY2021 | 31 Dec 2021 | 1.56 | 2.74B | 1.75B |
| Q3 FY2021 | 30 Sept 2021 | 1.62 | 2.85B | 1.76B |
| Q2 FY2021 | 30 Jun 2021 | 1.38 | 2.15B | 1.55B |
| Q1 FY2021 | 31 Mar 2021 | 1.76 | 3.00B | 1.71B |
| Q4 FY2020 | 31 Dec 2020 | 1.72 | 3.06B | 1.78B |
| Q3 FY2020 | 30 Sept 2020 | 1.40 | 3.35B | 2.39B |
| Q2 FY2020 | 30 Jun 2020 | 1.29 | 2.38B | 1.84B |
| Q1 FY2020 | 31 Mar 2020 | 1.38 | 1.56B | 1.13B |
| Q4 FY2019 | 31 Dec 2019 | 1.25 | 2.49B | 1.99B |
| Q3 FY2019 | 30 Sept 2019 | 0.88 | 1.78B | 2.01B |
| Q2 FY2019 | 30 Jun 2019 | 0.82 | 1.57B | 1.90B |
| Q1 FY2019 | 31 Mar 2019 | 0.78 | 1.78B | 2.28B |
| Q4 FY2018 | 31 Dec 2018 | 0.94 | 1.39B | 1.49B |
| Q3 FY2018 | 30 Sept 2018 | 1.15 | 1.60B | 1.39B |
| Q2 FY2018 | 30 Jun 2018 | 1.12 | 1.42B | 1.26B |
| Q1 FY2018 | 31 Mar 2018 | 1.23 | 1.37B | 1.12B |
| Q4 FY2017 | 31 Dec 2017 | 1.24 | 1.31B | 1.06B |
| Q3 FY2017 | 30 Sept 2017 | 1.47 | 1.54B | 1.05B |
| Q2 FY2017 | 30 Jun 2017 | 1.64 | 1.50B | 917.00M |
| Q1 FY2017 | 31 Mar 2017 | 1.58 | 1.56B | 985.00M |
| Q4 FY2016 | 31 Dec 2016 | 1.56 | 1.53B | 981.00M |
| Q3 FY2016 | 30 Sept 2016 | 1.57 | 1.64B | 1.05B |
| Q2 FY2016 | 30 Jun 2016 | 1.36 | 1.51B | 1.11B |
| Q1 FY2016 | 31 Mar 2016 | 1.37 | 1.49B | 1.09B |
| Q4 FY2015 | 31 Dec 2015 | 1.28 | 1.50B | 1.17B |
| Q3 FY2015 | 30 Sept 2015 | 1.45 | 1.65B | 1.13B |
| Q2 FY2015 | 30 Jun 2015 | 1.23 | 1.53B | 1.24B |
| Q1 FY2015 | 31 Mar 2015 | 1.14 | 2.38B | 2.09B |
| Q4 FY2014 | 31 Dec 2014 | 0.94 | 1.60B | 1.71B |
| Q3 FY2014 | 30 Sept 2014 | 1.31 | 1.56B | 1.19B |
| Q2 FY2014 | 30 Jun 2014 | 1.20 | 1.51B | 1.26B |
| Q1 FY2014 | 31 Mar 2014 | 1.25 | 1.49B | 1.19B |
| Q4 FY2013 | 31 Dec 2013 | 1.22 | 1.38B | 1.13B |
| Q3 FY2013 | 30 Sept 2013 | 1.15 | 1.43B | 1.24B |
| Q2 FY2013 | 30 Jun 2013 | 1.14 | 1.47B | 1.29B |
| Q1 FY2013 | 31 Mar 2013 | 1.21 | 1.46B | 1.21B |
| Q4 FY2012 | 31 Dec 2012 | 1.49 | 1.56B | 1.05B |
| Q3 FY2012 | 30 Sept 2012 | 1.38 | 1.47B | 1.07B |
| Q2 FY2012 | 30 Jun 2012 | 1.12 | 1.48B | 1.32B |
| Q1 FY2012 | 31 Mar 2012 | 1.00 | 1.52B | 1.53B |
| Q4 FY2011 | 31 Dec 2011 | 0.90 | 1.40B | 1.56B |
| Q3 FY2011 | 30 Sept 2011 | 0.79 | 1.40B | 1.76B |
| Q2 FY2011 | 30 Jun 2011 | 0.74 | 1.48B | 1.99B |
| Q1 FY2011 | 31 Mar 2011 | 1.48 | 2.26B | 1.53B |
| Q4 FY2010 | 31 Dec 2010 | 1.32 | 1.61B | 1.21B |
| Q3 FY2010 | 30 Sept 2010 | 1.35 | 1.55B | 1.15B |
| Q2 FY2010 | 30 Jun 2010 | 1.64 | 1.63B | 995.50M |
| Q1 FY2010 | 31 Mar 2010 | 1.53 | 1.65B | 1.08B |
| Q4 FY2009 | 31 Dec 2009 | 1.59 | 1.68B | 1.06B |
| Q3 FY2009 | 30 Sept 2009 | 1.48 | 1.47B | 990.90M |
| Q2 FY2009 | 30 Jun 2009 | 1.31 | 1.34B | 1.02B |
| Q1 FY2009 | 31 Mar 2009 | 1.17 | 1.48B | 1.27B |
| Q4 FY2008 | 31 Dec 2008 | 1.22 | 1.50B | 1.22B |
| Q3 FY2008 | 30 Sept 2008 | 1.25 | 1.55B | 1.24B |
| Q2 FY2008 | 30 Jun 2008 | 1.25 | 1.42B | 1.13B |
| Q1 FY2008 | 31 Mar 2008 | 1.23 | 1.46B | 1.19B |
| Q4 FY2007 | 31 Dec 2007 | 1.07 | 1.37B | 1.29B |
| Q3 FY2007 | 30 Sept 2007 | 1.20 | 1.45B | 1.20B |
| Q2 FY2007 | 30 Jun 2007 | 1.22 | 1.42B | 1.16B |
| Q1 FY2007 | 31 Mar 2007 | 0.80 | 1.25B | 1.57B |
| Q4 FY2006 | 31 Dec 2006 | 1.03 | 1.19B | 1.15B |
| Q3 FY2006 | 30 Sept 2006 | 1.05 | 1.24B | 1.18B |
| Q2 FY2006 | 30 Jun 2006 | 1.10 | 1.22B | 1.11B |
| Q1 FY2006 | 31 Mar 2006 | 1.06 | 1.20B | 1.13B |
| Q4 FY2005 | 31 Dec 2005 | 0.97 | 1.07B | 1.10B |
| Q3 FY2005 | 30 Sept 2005 | 0.97 | 1.15B | 1.19B |
| Q2 FY2005 | 30 Jun 2005 | 1.22 | 1.14B | 940.17M |
| Q1 FY2005 | 31 Mar 2005 | 1.11 | 1.04B | 932.26M |
| Q4 FY2004 | 31 Dec 2004 | 0.89 | 931.08M | 1.04B |
| Q3 FY2004 | 30 Sept 2004 | 1.43 | 1.11B | 779.89M |
| Q2 FY2004 | 30 Jun 2004 | 1.36 | 1.04B | 770.04M |
| Q1 FY2004 | 31 Mar 2004 | 1.62 | 1.07B | 662.00M |
| Q4 FY2003 | 31 Dec 2003 | 1.38 | 995.79M | 723.80M |
| Q3 FY2003 | 30 Sept 2003 | 1.44 | 972.00M | 673.55M |
| Q2 FY2003 | 30 Jun 2003 | 1.43 | 953.13M | 668.83M |
| Q1 FY2003 | 31 Mar 2003 | 1.35 | 906.92M | 672.92M |
| Q4 FY2002 | 31 Dec 2002 | 1.30 | 824.44M | 635.98M |
| Q3 FY2002 | 30 Sept 2002 | 1.08 | 930.15M | 861.51M |
| Q2 FY2002 | 30 Jun 2002 | 0.99 | 933.81M | 946.58M |
| Q1 FY2002 | 31 Mar 2002 | 1.52 | 949.87M | 623.69M |
| Q4 FY2001 | 31 Dec 2001 | 1.33 | 876.51M | 658.62M |
| Q3 FY2001 | 30 Sept 2001 | 1.11 | 988.41M | 888.67M |
| Q2 FY2001 | 30 Jun 2001 | 1.07 | 956.66M | 890.06M |
| Q1 FY2001 | 31 Mar 2001 | 1.04 | 952.81M | 920.02M |
| Q4 FY2000 | 31 Dec 2000 | 1.03 | 980.69M | 954.99M |
| Q3 FY2000 | 30 Sept 2000 | 1.06 | 1.05B | 987.18M |
| Q2 FY2000 | 30 Jun 2000 | 1.34 | 955.69M | 715.84M |
| Q1 FY2000 | 31 Mar 2000 | 1.33 | 830.42M | 622.53M |
| Q4 FY1999 | 31 Dec 1999 | 1.24 | 872.70M | 701.20M |
| Q3 FY1999 | 30 Sept 1999 | 1.37 | 875.00M | 638.80M |
| Q2 FY1999 | 30 Jun 1999 | 1.68 | 527.80M | 313.40M |
| Q1 FY1999 | 31 Mar 1999 | 1.72 | 530.60M | 309.20M |
| Q4 FY1998 | 31 Dec 1998 | 1.87 | 578.20M | 309.50M |
| Q3 FY1998 | 30 Sept 1998 | 1.85 | 561.70M | 303.40M |
| Q2 FY1998 | 30 Jun 1998 | 1.98 | 551.10M | 278.40M |
| Q1 FY1998 | 31 Mar 1998 | 1.94 | 581.60M | 299.40M |
| Q4 FY1997 | 31 Dec 1997 | 1.94 | 571.90M | 295.10M |
| Q3 FY1997 | 30 Sept 1997 | 1.98 | 553.40M | 279.00M |
| Q2 FY1997 | 30 Jun 1997 | 2.08 | 523.50M | 251.50M |
| Q1 FY1997 | 31 Mar 1997 | 2.15 | 516.50M | 240.10M |
| Q4 FY1996 | 31 Dec 1996 | 2.05 | 511.00M | 249.00M |
| Q3 FY1996 | 30 Sept 1996 | 1.26 | 549.00M | 434.00M |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios
Common questions about Quest Diagnostics's current ratio
Source: Financial Modeling Prep
